ADVFN - Advanced Financial Network.
HOME» NYSE » T » TMO Stock Price » TMO Stock News

Thermo Electron Share News

 Thermo Fisher Scientific Stock Price
TMO Stock Price
 Thermo Fisher Scientific Stock Chart
TMO Stock Chart
 Thermo Fisher Scientific Stock News
TMO Stock News
 Thermo Fisher Scientific Company Information
TMO Company Information
 Thermo Fisher Scientific Stock Trades
TMO Stock Trades

Thermo Fisher Scientific 2nd Quarter Net Down 55%; Revenue Rises

By Saabira Chaudhuri Thermo Fisher Scientific Inc.'s (TMO) second-quarter earnings fell 55% as the supplier of analytical technologies and laboratory products faced a tough comparison with a year-ago period that saw gains from business sales, though revenue climbed. The company cut its full-year revenue outlook to between $12.14 billion to $12.26 billion, citing discontinued operations, an acquisition and unfavorable foreign exchange. However, it raised its earnings estimate for the year to between $4.74 to $4.84 a share, citing new share buyback authorization among other reasons. In April, Thermo Fisher boosted its full-year earnings estimate to $4.71 to $4.83 a share on revenue of $12.27 billion to $12.43 billion. Thermo Fisher's sales have improved in recent quarters, aided by acquisitions and its expansion into Asia-Pacific markets. The company also launched new products last year to expand its mass spectrometry, specialty diagnostics and laboratory equipment lineup. But higher research and development costs, on top of restructuring and acquisition charges, have challenged its bottom line of late. Earlier this month, Thermo Fisher agreed to buy transplant diagnostics test provider One Lambda for $925 million in cash to boost its existing immunosuppressant monitoring assays business. In response to the news, three credit ratings firms lowered their investment-grade ratings on the company, citing the increased debt associated with the deal. At the same time, the company unveiled plans to repurchase an additional $500 million of stock through Dec. 31. Thermo Fisher reported a profit of $233.8 million, or 63 cents a share, down from $523.4 million, or $1.36 a share, a year earlier. The latest results included a $51.1 million loss on disposal of discontinued operations versus a previous-year $305.8 million gain. Excluding items such as asset amortization, restructuring and acquisition-related costs, earnings rose to $1.22 from 99 cents. Revenue jumped 8.9% to $3.11 billion. Analysts polled by Thomson Reuters had most recently forecast earnings of $1.16 on revenue of $3.05 billion. Operating margin rose to 11.8% from 9.3%. The laboratory products and services segment--the company's largest top-line contributor--saw a 2% revenue increase while its operating profit rose 0.6%. The analytical technologies segment's revenue jumped 8% and earnings grew 10%. Specialty diagnostics segment revenue increased 28%, while its income was up 47%. Shares closed at $49.78 Tuesday and were inactive premarket. The stock is down 23% over the past 12 months. Write to Saabira Chaudhuri at [email protected] Subscribe to WSJ:

Stock News for Thermo Electron (TMO)
03/16/201717:12:33Statement of Changes in Beneficial Ownership (4)
03/16/201717:09:05Statement of Changes in Beneficial Ownership (4)
03/16/201707:05:42Securities Registration (section 12(b)) (8-a12b)
03/16/201706:58:44Current Report Filing (8-k)
03/13/201717:16:28Statement of Changes in Beneficial Ownership (4)
03/10/201717:00:59Statement of Changes in Beneficial Ownership (4)
03/09/201716:14:45Statement of Changes in Beneficial Ownership (4)
03/08/201717:17:02Statement of Changes in Beneficial Ownership (4)
03/08/201717:13:48Statement of Changes in Beneficial Ownership (4)
03/08/201717:12:03Statement of Changes in Beneficial Ownership (4)
03/08/201716:45:18Current Report Filing (8-k)
03/08/201716:42:09Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
03/07/201717:05:00Thermo Fisher Scientific Prices Offering of Euro-Denominated...
03/07/201716:17:25Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
03/07/201708:00:00Thermo Fisher Scientific to Present at the Barclays Global Healthcare...
03/07/201706:07:48Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
03/06/201709:00:00Thermo Fisher Scientific Showcases Integrated Analytical Workflows...
03/02/201718:01:58Statement of Changes in Beneficial Ownership (4)
03/02/201718:00:07Statement of Changes in Beneficial Ownership (4)
03/02/201718:00:07Statement of Changes in Beneficial Ownership (4)

Thermo Electron and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations